Scheduled to open in the first half of 2024,
Lilly
's new
Gateway Labs
location, in partnership with Alexandria Real Estate Equities, will feature a world-class, state-of-the-art lab facility to support early-stage scientific entrepreneurs and companies
Eli Lilly and Company
(NYSE: LLY) today announced plans to open its first-ever
Lilly Gateway Labs
location in
San Diego, Calif.
in the first half of 2024.
Gateway Labs
is
Lilly
's shared innovation accelerator that provides participating companies with state-of-the-art lab space and unique access to
Lilly
scientists, researchers and executives, as well as exposure to
Lilly
's functional and scientific expertise. This will be the company's third
Gateway Labs
location, with additional sites located in
San Francisco
and
Boston
.
"We are excited to expand our footprint in
San Diego
as it is home to a thriving life sciences community," said
Daniel Skovronsky
, M.D., Ph.D., chief scientific officer, and president,
Lilly Research Laboratories
. "By providing lab space and access to
Lilly
's scientific expertise, we can support scientists from research institutes, universities and small biotech companies as they work to discover the next generation of medicines for patients."
Companies located at
Gateway Labs
have the opportunity to collaborate with
Lilly
and each other on research of mutual interest, participate in shared learning and scientific symposia with
Lilly
experts and partners, and have the potential for financial investment directly from
Lilly
, venture capital funds, or both. In partnership with Alexandria Real Estate Equities Inc. (ARE), the new site will merge
Lilly
's scientific expertise with ARE's operational excellence to create a world-class facility.
The new site will be located in Alexandria's
University Town Center
(UTC) campus, and offer nearly 62,000 square feet of rentable, flexibly-designed lab space, as well as open workstations for fostering scientific exchange and collaboration among participating companies. It is expected to accommodate 10 companies and more than 120 biotech and
Lilly
employees.
"
Lilly
has been supporting early-phase external innovation for decades, and we are excited to continue to expand our
Gateway Labs
shared innovation spaces to a larger network of life science startups" said
Julie Gilmore
, Ph.D., vice president, and global head of
Gateway Labs
. "The expansion of our
Gateway Labs
model will grant scientists access to
Lilly
's research operations, mentorship and expertise in an environment made to foster scientific breakthroughs."
Companies interested in joining
Lilly Gateway Labs
should visit www.gatewaylabs.lilly.com and contact GatewayLabs@lilly.com.
About
Lilly
Lilly
unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news or follow us on Facebook, Instagram and LinkedIn. C-LLY
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-announces-plans-to-open-its-first-ever-gateway-labs-site-in-san-diego-301998388.html
SOURCE
Eli Lilly and Company
